FDA finalizes long-awaited intended use rule
Regulatory NewsMichael Mezher
Advertising, Promotion and LabelingBiologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsMedical DevicesNorth AmericaPharmaceuticalsProduct LifecycleRegulatory Intelligence/Policy